Role of Oxygen in Cancer: Looking Beyond Hypoxia

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)

Volume 17, 14 Issues, 2017

Download PDF Flyer

Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Michelle Prudhomme
Institut de Chimie de Clermont-Ferrand
Université Clermont Auvergne

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Role of Oxygen in Cancer: Looking Beyond Hypoxia

Anti-Cancer Agents in Medicinal Chemistry, 9(5): 517-525.

Author(s): Miguel Lopez-Lazaro.

Affiliation: Department of Pharmacology, Faculty of Pharmacy, C/ Profesor Garcia Gonzalez, 41012 Sevilla, Spain.


Although cancer is considered to be a disease caused by DNA alterations, the high genetic variability of tumor cells makes it difficult to exploit these alterations for the treatment of cancer. The influence of non-genetic factors on cancer is increasingly being acknowledged and a growing line of research suggests that hypoxia (a decrease in normal oxygen levels) may play a fundamental role in the development of this disease. This line of research is supported by the fact that tumors often have hypoxic areas, that hypoxia activates the hypoxia-inducible factor 1 (HIF-1) and that HIF-1 activation plays a key role in cancer development. Evidence suggests, however, that the idea of hypoxia playing a central role in cancer development has some drawbacks. For instance, hypoxia has not been found in many tumors, HIF-1 activation has been observed in non-hypoxic tumor areas, and hypoxic tumor cells commonly have a reduced nutrient supply that restricts cell proliferation and tumor growth. This article reviews the literature that does not support the idea of hypoxia playing a central role in cancer development and discusses a broader view in which the role of oxygen in cancer is not limited to a reduction in its normal levels. According to this novel view, a deviation of the oxygen metabolism from the pathway that generates energy to the pathway that produces reactive oxygen species is crucial for cancer development. Interestingly, this switch in oxygen metabolism occurs under both hypoxic and normoxic conditions and may be exploited therapeutically.


Glycolysis, HIF-1, reactive oxygen species, hydrogen peroxide, cell proliferation, tumor growth, metastasis, carcinogenesis.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 5
First Page: 517
Last Page: 525
Page Count: 9
DOI: 10.2174/187152009788451806
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science